Fundraising Fox

WuXi PharmaTech

4 known investors

wuxiapptec.com ↗

WuXi AppTec provides R&D and manufacturing services to the pharmaceutical and life sciences industries through a CRDMO (Contract Research, Development, and Manufacturing Organization) platform. It supports drug developers across 30+ countries with end-to-end capabilities spanning operations in Asia, Europe, and North America.

Advanced ManufacturingBiotechHealthtech

Investors · 4

Highlight CapitalNanjin · $2.8M – $74M
Huangpu River CapitalShanghai
Vivo CapitalPalo Alto · $10M – $50M
Legend CapitalreportedBeijing · $2.9M – $156Mvia Frank Hong · inferred

In the news

WuXi venture unit raises $290M for 'find in U.S., build in China' venture fund | Fierce Pharmafiercepharma.com · Dec 2015Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx | Fierce Biotechfiercebiotech.com · May 2015Phagelux Of China Raises Funds From WuXi PharmaTech Co., Ltd. - BioSpacebiospace.com · Mar 2014WuXi PharmaTech helps pump $42m into Ivenix - Global Venturingglobalventuring.com

Frequently asked questions

What does WuXi PharmaTech do?
WuXi AppTec provides R&D and manufacturing services to the pharmaceutical and life sciences industries through a CRDMO (Contract Research, Development, and Manufacturing Organization) platform. It supports drug developers across 30+ countries with end-to-end capabilities spanning operations in Asia, Europe, and North America.
Who are WuXi PharmaTech's investors?
WuXi PharmaTech's investors include Highlight Capital, Huangpu River Capital, Vivo Capital, Legend Capital.